ID   OPLA_HUMAN              Reviewed;        1288 AA.
AC   O14841; A5PKY8; Q75W65; Q9Y4Q0;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 3.
DT   12-APR-2017, entry version 133.
DE   RecName: Full=5-oxoprolinase;
DE            EC=3.5.2.9;
DE   AltName: Full=5-oxo-L-prolinase;
DE            Short=5-OPase;
DE   AltName: Full=Pyroglutamase;
GN   Name=OPLAH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=14993790; DOI=10.1248/bpb.27.288;
RA   Watanabe T., Abe K., Ishikawa H., Iijima Y.;
RT   "Bovine 5-oxo-L-prolinase: simple assay method, purification, cDNA
RT   cloning, and detection of mRNA in the coronary artery.";
RL   Biol. Pharm. Bull. 27:288-294(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 229-1288.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 901-1096.
RA   Debella L.R., Wood S.;
RT   "Human 5-oxo-L-prolinase partial sequence.";
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   INVOLVEMENT IN OPLAHD.
RX   PubMed=21651516; DOI=10.1111/j.1399-0004.2011.01728.x;
RA   Almaghlouth I., Mohamed J., Al-Amoudi M., Al-Ahaidib L., Al-Odaib A.,
RA   Alkuraya F.;
RT   "5-Oxoprolinase deficiency: report of the first human OPLAH
RT   mutation.";
RL   Clin. Genet. 82:193-196(2012).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-151, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the cleavage of 5-oxo-L-proline to form L-
CC       glutamate coupled to the hydrolysis of ATP to ADP and inorganic
CC       phosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + 5-oxo-L-proline + 2 H(2)O = ADP +
CC       phosphate + L-glutamate.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A
CC       disorder characterized by calcium oxalate/carbonate urolithiasis,
CC       and excessive urinary 5-oxo-L-proline. Affected individuals have
CC       recurrent episodes of vomiting, diarrhea, and abdominal pain.
CC       {ECO:0000269|PubMed:21651516}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the oxoprolinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB81519.1; Type=Frameshift; Positions=1046, 1068, 1080; Evidence={ECO:0000305};
CC       Sequence=CAB46426.2; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB122018; BAD13434.1; -; mRNA.
DR   EMBL; BC142672; AAI42673.1; -; mRNA.
DR   EMBL; AL096750; CAB46426.2; ALT_FRAME; mRNA.
DR   EMBL; AH005594; AAB81519.1; ALT_FRAME; Genomic_DNA.
DR   CCDS; CCDS75802.1; -.
DR   PIR; T12537; T12537.
DR   RefSeq; NP_060040.1; NM_017570.4.
DR   UniGene; Hs.305882; -.
DR   ProteinModelPortal; O14841; -.
DR   SMR; O14841; -.
DR   BioGrid; 117922; 1.
DR   IntAct; O14841; 3.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   iPTMnet; O14841; -.
DR   PhosphoSitePlus; O14841; -.
DR   BioMuta; OPLAH; -.
DR   EPD; O14841; -.
DR   MaxQB; O14841; -.
DR   PeptideAtlas; O14841; -.
DR   PRIDE; O14841; -.
DR   DNASU; 26873; -.
DR   Ensembl; ENST00000618853; ENSP00000480476; ENSG00000178814.
DR   GeneID; 26873; -.
DR   KEGG; hsa:26873; -.
DR   UCSC; uc033cce.2; human.
DR   CTD; 26873; -.
DR   DisGeNET; 26873; -.
DR   GeneCards; OPLAH; -.
DR   HGNC; HGNC:8149; OPLAH.
DR   HPA; HPA026562; -.
DR   HPA; HPA028260; -.
DR   HPA; HPA052429; -.
DR   MalaCards; OPLAH; -.
DR   MIM; 260005; phenotype.
DR   MIM; 614243; gene.
DR   neXtProt; NX_O14841; -.
DR   OpenTargets; ENSG00000178814; -.
DR   Orphanet; 33572; 5-oxoprolinase deficiency.
DR   PharmGKB; PA31935; -.
DR   GeneTree; ENSGT00390000013463; -.
DR   HOGENOM; HOG000047200; -.
DR   HOVERGEN; HBG007870; -.
DR   InParanoid; O14841; -.
DR   KO; K01469; -.
DR   OMA; PLTVTDC; -.
DR   OrthoDB; EOG091G00VX; -.
DR   PhylomeDB; O14841; -.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   GenomeRNAi; 26873; -.
DR   PRO; PR:O14841; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000178814; -.
DR   CleanEx; HS_OPLAH; -.
DR   ExpressionAtlas; O14841; baseline and differential.
DR   Genevisible; O14841; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0017168; F:5-oxoprolinase (ATP-hydrolyzing) activity; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006750; P:glutathione biosynthetic process; TAS:Reactome.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR008040; Hydant_A_N.
DR   InterPro; IPR002821; Hydantoinase_A.
DR   InterPro; IPR003692; Hydantoinase_B.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF05378; Hydant_A_N; 1.
DR   Pfam; PF01968; Hydantoinase_A; 1.
DR   Pfam; PF02538; Hydantoinase_B; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Hydrolase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   1288       5-oxoprolinase.
FT                                /FTId=PRO_0000208577.
FT   MOD_RES     151    151       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1265   1265       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97608}.
FT   VARIANT     284    284       S -> R (in dbSNP:rs3935209).
FT                                /FTId=VAR_050425.
FT   CONFLICT   1084   1089       QRVVDV -> NAWWMF (in Ref. 4; AAB81519).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1288 AA;  137457 MW;  999AC0FA497750F2 CRC64;
     MGSPEGRFHF AIDRGGTFTD VFAQCPGGHV RVLKLLSEDP ANYADAPTEG IRRILEQEAG
     MLLPRDQPLD SSHIASIRMG TTVATNALLE RKGERVALLV TRGFRDLLHI GTQARGDLFD
     LAVPMPEVLY EEVLEVDERV VLHRGEAGTG TPVKGRTGDL LEVQQPVDLG ALRGKLEGLL
     SRGIRSLAVV LMHSYTWAQH EQQVGVLARE LGFTHVSLSS EAMPMVRIVP RGHTACADAY
     LTPAIQRYVQ GFCRGFQGQL KDVQVLFMRS DGGLAPMDTF SGSSAVLSGP AGGVVGYSAT
     TYQQEGGQPV IGFDMGGTST DVSRYAGEFE HVFEASTAGV TLQAPQLDIN TVAAGGGSRL
     FFRSGLFVVG PESAGAHPGP ACYRKGGPVT VTDANLVLGR LLPASFPCIF GPGENQPLSP
     EASRKALEAV ATEVNSFLTN GPCPASPLSL EEVAMGFVRV ANEAMCRPIR ALTQARGHDP
     SAHVLACFGG AGGQHACAIA RALGMDTVHI HRHSGLLSAL GLALADVVHE AQEPCSLLYA
     PETFVQLDQR LSRLEEQCVD ALQAQGFPRS QISTESFLHL RYQGTDCALM VSAHQHPATA
     RSPRAGDFGA AFVERYMREF GFVIPERPVV VDDVRVRGTG RSGLRLEDAP KAQTGPPRVD
     KMTQCYFEGG YQETPVYLLA ELGYGHKLHG PCLIIDSNST ILVEPGCQAE VTKTGDICIS
     VGAEVPGTVG PQLDPIQLSI FSHRFMSIAE QMGRILQRTA ISTNIKERLD FSCALFGPDG
     GLVSNAPHIP VHLGAMQETV QFQIQHLGAD LHPGDVLLSN HPSAGGSHLP DLTVITPVFW
     PGQTRPVFYV ASRGHHADIG GITPGSMPPH STMLQQEGAV FLSFKLVQGG VFQEEAVTEA
     LRAPGKVPNC SGTRNLHDNL SDLRAQVAAN QKGIQLVGEL IGQYGLDVVQ AYMGHIQANA
     ELAVRDMLRA FGTSRQARGL PLEVSSEDHM DDGSPIRLRV QISLSQGSAV FDFSGTGPEV
     FGNLNAPRAV TLSALIYCLR CLVGRDIPLN QGCLAPVRVV IPRGSILDPS PEAAVVGGNV
     LTSQRVVDVI LGAFGACAAS QGCMNNVTLG NAHMGYYETV AGGAGAGPSW HGRSGVHSHM
     TNTRITDPEI LESRYPVILR RFELRRGSGG RGRFRGGDGV TRELLFREEA LLSVLTERRA
     FRPYGLHGGE PGARGLNLLI RKNGRTVNLG GKTSVTVYPG DVFCLHTPGG GGYGDPEDPA
     PPPGSPPQAL AFPEHGSVYE YRRAQEAV
//
